EL
25
4
HCA
44
-2
ADT
53
3
CTSH
56
2
PYPL
54
2
IR
66
3
EMN
60
4
TGT
22
2
EXC
53
-3
GT
62
6
KMI
67
-2
M
37
12
DVN
21
3
PFE
23
7
PPL
54
-5
IPG
56
3
COF
60
2
PAYX
53
2
CVX
47
3
DHI
48
4
EL
25
4
HCA
44
-2
ADT
53
3
CTSH
56
2
PYPL
54
2
IR
66
3
EMN
60
4
TGT
22
2
EXC
53
-3
GT
62
6
KMI
67
-2
M
37
12
DVN
21
3
PFE
23
7
PPL
54
-5
IPG
56
3
COF
60
2
PAYX
53
2
CVX
47
3
DHI
48
4
Financhill
Back

Glaukos Vs. Perspective Therapeutics Industry Stock Comparison

Buy
53

GKOS
Glaukos

Last Price:
144.11
Seasonality Move:
16.11%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Buy
53
Glaukos (GKOS) is a Buy

Is Glaukos a Buy, Sell or Hold?

  • The current Glaukos [GKOS] share price is $144.00. The Score for GKOS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • GKOS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GKOS Stock Price Chart

What is Glaukos's stock price today?

  • The Glaukos share price today is $144.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GKOS is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

GKOS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.93 Buy
Relative Strength Index (14 RSI): 60.27 Buy
Chaikin Money Flow: 82266 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (131.86 - 142.14) Buy
Bollinger Bands (100): (121.1 - 135.4) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

GKOS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 140.97 Buy
20-day SMA: 138.5 Buy
50-day SMA: 132.36 Buy
200-day SMA: 114.5 Buy
8-day EMA: 141.27 Buy
20-day EMA: 138.59 Buy
50-day EMA: 133.85 Buy
200-day EMA: 115.82 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Glaukos Earnings Growth & GKOS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.73 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Glaukos Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):